Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 307

1.

Bedside predictors of outcome in meningitis: Time to upgrade the GCS?

Berger JR, Klein M.

Neurology. 2019 May 28;92(22):1035-1036. doi: 10.1212/WNL.0000000000007603. Epub 2019 May 3. No abstract available.

PMID:
31053669
2.

Misdiagnosis of multiple sclerosis in a female heterozygote with Fabry's disease.

Berger JR.

Mult Scler Relat Disord. 2019 May;30:45-47. doi: 10.1016/j.msard.2019.01.040. Epub 2019 Jan 30.

PMID:
30738278
3.

Lyme myelopathy: Case report and literature review of a rare but treatable disorder.

Kaiser EA, George DK, Rubenstein MN, Berger JR.

Mult Scler Relat Disord. 2019 Apr;29:1-6. doi: 10.1016/j.msard.2018.12.034. Epub 2019 Jan 3. Review.

PMID:
30654245
4.

Author response: Progressive multifocal leukoencephalopathy after fingolimod treatment.

Berger JR, Cree BA, Greenberg B, Hemmer B, Ward BJ, Dong VM, Merschhemke M.

Neurology. 2019 Jan 15;92(3):151. doi: 10.1212/WNL.0000000000006774. No abstract available.

PMID:
30643034
5.

Association of Scheduled vs Emergency-Only Dialysis With Health Outcomes and Costs in Undocumented Immigrants With End-stage Renal Disease.

Nguyen OK, Vazquez MA, Charles L, Berger JR, Quiñones H, Fuquay R, Sanders JM, Kapinos KA, Halm EA, Makam AN.

JAMA Intern Med. 2019 Feb 1;179(2):175-183. doi: 10.1001/jamainternmed.2018.5866.

PMID:
30575859
6.

Uncovering the association between fatigue and fatigability in multiple sclerosis using cognitive control.

Cehelyk EK, Harvey DY, Grubb ML, Jalel R, El-Sibai MS, Markowitz CE, Berger JR, Hamilton RH, Chahin S.

Mult Scler Relat Disord. 2019 Jan;27:269-275. doi: 10.1016/j.msard.2018.10.112. Epub 2018 Oct 27.

PMID:
30423531
7.

Progressive Multifocal Leukoencephalopathy.

Grebenciucova E, Berger JR.

Neurol Clin. 2018 Nov;36(4):739-750. doi: 10.1016/j.ncl.2018.06.002. Review.

PMID:
30366552
8.

Deciding on the Best Multiple Sclerosis Therapy: Tough Choices.

Berger JR, Markowitz C.

JAMA Neurol. 2018 Dec 1;75(12):1461-1462. doi: 10.1001/jamaneurol.2018.2689. No abstract available.

PMID:
30242377
9.

Neurological and Ophthalmological Manifestations of Varicella Zoster Virus.

Kedar S, Jayagopal LN, Berger JR.

J Neuroophthalmol. 2019 Jun;39(2):220-231. doi: 10.1097/WNO.0000000000000721.

PMID:
30188405
10.

Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group.

Stern BJ, Royal W 3rd, Gelfand JM, Clifford DB, Tavee J, Pawate S, Berger JR, Aksamit AJ, Krumholz A, Pardo CA, Moller DR, Judson MA, Drent M, Baughman RP.

JAMA Neurol. 2018 Dec 1;75(12):1546-1553. doi: 10.1001/jamaneurol.2018.2295.

PMID:
30167654
11.

A Programme for Risk Assessment and Minimisation of Progressive Multifocal Leukoencephalopathy Developed for Vedolizumab Clinical Trials.

Parikh A, Stephens K, Major E, Fox I, Milch C, Sankoh S, Lev MH, Provenzale JM, Shick J, Patti M, McAuliffe M, Berger JR, Clifford DB.

Drug Saf. 2018 Aug;41(8):807-816. doi: 10.1007/s40264-018-0669-8.

12.

Progressive multifocal leukoencephalopathy after fingolimod treatment.

Berger JR, Cree BA, Greenberg B, Hemmer B, Ward BJ, Dong VM, Merschhemke M.

Neurology. 2018 May 15;90(20):e1815-e1821. doi: 10.1212/WNL.0000000000005529. Epub 2018 Apr 18.

13.

Correction to: Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event.

Berger JR, Malik V, Lacey S, Brunetta P, Lehane PB.

J Neurovirol. 2018 Jun;24(3):332. doi: 10.1007/s13365-018-0637-1.

PMID:
29637430
14.

Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event.

Berger JR, Malik V, Lacey S, Brunetta P, Lehane PB.

J Neurovirol. 2018 Jun;24(3):323-331. doi: 10.1007/s13365-018-0615-7. Epub 2018 Mar 5. Erratum in: J Neurovirol. 2018 Apr 10;:.

15.

Letter re: Burnout, career satisfaction, and well-being among US neurologists in 2016.

Berger JR.

Neurology. 2017 Oct 10;89(15):1649-1650. doi: 10.1212/WNL.0000000000004480. Epub 2017 Oct 9. No abstract available.

PMID:
28993529
16.

Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.

Williamson EML, Berger JR.

Neurotherapeutics. 2017 Oct;14(4):961-973. doi: 10.1007/s13311-017-0570-7. Review.

17.

Immunosenescence: the Role of Aging in the Predisposition to Neuro-Infectious Complications Arising from the Treatment of Multiple Sclerosis.

Grebenciucova E, Berger JR.

Curr Neurol Neurosci Rep. 2017 Aug;17(8):61. doi: 10.1007/s11910-017-0771-9. Review.

PMID:
28669032
18.

Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR).

Sabol RA, Noxon V, Sartor O, Berger JR, Qureshi Z, Raisch DW, Norris LB, Yarnold PR, Georgantopoulos P, Hrushesky WJ, Bobolts L, Ray P, Lebby A, Kane RC, Bennett CL.

Cancer Med. 2017 Jul;6(7):1541-1551. doi: 10.1002/cam4.1098. Epub 2017 Jun 20. Review.

19.

The financial contribution of the multiple sclerosis specialist.

Berger JR.

Neurol Clin Pract. 2017 Jun;7(3):246-255. doi: 10.1212/CPJ.0000000000000360. Review.

20.

Classifying PML risk with disease modifying therapies.

Berger JR.

Mult Scler Relat Disord. 2017 Feb;12:59-63. doi: 10.1016/j.msard.2017.01.006. Epub 2017 Jan 6. Review.

PMID:
28283109
21.

Distribution and Quantity of Sites of John Cunningham Virus Persistence in Immunologically Healthy Patients: Correlation With John Cunningham Virus Antibody and Urine John Cunningham Virus DNA.

Berger JR, Miller CS, Danaher RJ, Doyle K, Simon KJ, Norton E, Gorelik L, Cahir-McFarland E, Singhal D, Hack N, Owens JR, Nelson PT, Neltner JH.

JAMA Neurol. 2017 Apr 1;74(4):437-444. doi: 10.1001/jamaneurol.2016.5537.

PMID:
28241186
22.

Closing in on an infectious etiology of motor neuron disease.

Berger JR, Power C.

Neurology. 2016 Oct 25;87(17):1750-1751. Epub 2016 Sep 24. No abstract available.

PMID:
27664984
23.

Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia.

Bennett CL, Berger JR, Sartor O, Carson KR, Hrushesky WJ, Georgantopoulos P, Raisch DW, Norris LB, Armitage JO.

Br J Haematol. 2018 Jan;180(2):301-304. doi: 10.1111/bjh.14322. Epub 2016 Sep 21. No abstract available.

PMID:
27649938
24.

Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy.

Hoepner R, Kolb EM, Dahlhaus S, Hellwig K, Adams O, Kleiter I, Salmen A, Schneider R, Lukas C, Chan A, Berger JR, Gold R.

Mult Scler. 2017 May;23(6):830-835. doi: 10.1177/1352458516667241. Epub 2016 Sep 6.

PMID:
27600113
25.

CSF pleocytosis and syndrome of inappropriate antidiuretic hormone secretion in Creutzfeldt-Jakob disease.

Hamedani AG, McLane HC, Kimbaris G, Jacobs DA, Berger JR.

Neurol Clin Pract. 2016 Aug;6(4):e30-e32. doi: 10.1212/CPJ.0000000000000218. No abstract available.

26.

Next-generation sequencing of tissue: A logical extension.

Berger JR, Wilson MR.

Neurol Neuroimmunol Neuroinflamm. 2016 Jul 14;3(4):e261. doi: 10.1212/NXI.0000000000000261. eCollection 2016 Aug. No abstract available.

27.

Re-evaluating the incidence of natalizumab-associated progressive multifocal leukoencephalopathy.

Borchardt J, Berger JR.

Mult Scler Relat Disord. 2016 Jul;8:145-50. doi: 10.1016/j.msard.2016.03.005. Epub 2016 Apr 1. Review.

PMID:
27456891
28.

Erratum to: Reassessing the risk of natalizumab-associated PML.

Berger JR, Fox RJ.

J Neurovirol. 2016 Aug;22(4):536-537. No abstract available.

PMID:
27026534
29.

WEST NILE VIRUS MENINGO-ENCEPHALITIS: POSSIBLE SEXUAL TRANSMISSION.

Kelley RE, Berger JR, Kelley BP.

J La State Med Soc. 2016 Jan-Feb;168(1):21-2. Epub 2016 Feb 15.

PMID:
26986863
30.

Vaccines in Multiple Sclerosis.

Williamson EM, Chahin S, Berger JR.

Curr Neurol Neurosci Rep. 2016 Apr;16(4):36. doi: 10.1007/s11910-016-0637-6. Review.

PMID:
26922172
31.

Reassessing the risk of natalizumab-associated PML.

Berger JR, Fox RJ.

J Neurovirol. 2016 Aug;22(4):533-5. doi: 10.1007/s13365-016-0427-6. Epub 2016 Feb 3. Erratum in: J Neurovirol. 2016 Aug;22(4):536-7.

PMID:
26843383
32.

End-Stage Kidney Disease in the Elderly: Approach to Dialysis Initiation, Choosing Modality, and Predicting Outcomes.

Berger JR, Jaikaransingh V, Hedayati SS.

Adv Chronic Kidney Dis. 2016 Jan;23(1):36-43. doi: 10.1053/j.ackd.2015.08.005. Review.

PMID:
26709061
33.

Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy.

White MK, Sariyer IK, Gordon J, Delbue S, Pietropaolo V, Berger JR, Khalili K.

Rev Med Virol. 2016 Mar;26(2):102-14. doi: 10.1002/rmv.1866. Epub 2015 Dec 14. Review.

34.

Central Nervous System Infections With Immunomodulatory Therapies.

Williamson EM, Berger JR.

Continuum (Minneap Minn). 2015 Dec;21(6 Neuroinfectious Disease):1577-98. doi: 10.1212/CON.0000000000000245. Review.

PMID:
26633777
35.

Varicella zoster virus rhombencephalomyelitis following radiation therapy for oropharyngeal carcinoma.

Prelack MS, Patterson KR, Berger JR.

J Clin Neurosci. 2016 Mar;25:164-6. doi: 10.1016/j.jocn.2015.09.009. Epub 2015 Oct 23.

PMID:
26602800
36.

Use of Descriptive Terms in Medical Records-Reply.

Berger JR.

JAMA Neurol. 2015 Nov;72(11):1379. doi: 10.1001/jamaneurol.2015.2645. No abstract available.

PMID:
26551964
37.

Longitudinally extensive transverse myelitis suspected for isolated Neuro-Behçet: A diagnostic conundrum.

Al Sawaf A, Berger JR.

Mult Scler Relat Disord. 2015 Sep;4(5):395-399. doi: 10.1016/j.msard.2015.07.003. Epub 2015 Jul 8.

PMID:
26346785
38.

Editorial for JNV issue on PML.

Berger JR.

J Neurovirol. 2015 Dec;21(6):599-600. doi: 10.1007/s13365-015-0376-5. Epub 2015 Sep 2. No abstract available.

PMID:
26329137
39.

Spinal cord progressive multifocal leukoencephalopathy detected premortem by MRI.

Murayi R, Schmitt J, Woo JH, Berger JR.

J Neurovirol. 2015 Dec;21(6):688-90. doi: 10.1007/s13365-015-0342-2. Epub 2015 Jul 3. No abstract available.

PMID:
26139016
40.

Progressive Multifocal Leukoencephalopathy: Recent Advances and a Neuro-Ophthalmological Review.

Sudhakar P, Bachman DM, Mark AS, Berger JR, Kedar S.

J Neuroophthalmol. 2015 Sep;35(3):296-305. doi: 10.1097/WNO.0000000000000271. Review.

PMID:
26132966
41.

Rapidly progressive dementia with hypoglycorrhachia.

Siegler JE, Jacobs DA, Amado D, Adams JL, Berger JR.

J Clin Neurosci. 2015 Oct;22(10):1685-7. doi: 10.1016/j.jocn.2015.05.007. Epub 2015 Jun 19.

PMID:
26094562
42.

Animal Models for Progressive Multifocal Leukoencephalopathy.

White MK, Gordon J, Berger JR, Khalili K.

J Cell Physiol. 2015 Dec;230(12):2869-74. doi: 10.1002/jcp.25047. Review.

43.

Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica.

Berger JR, Neltner J, Smith C, Cambi F.

Mult Scler Relat Disord. 2014 Nov;3(6):728-31. doi: 10.1016/j.msard.2014.08.004. Epub 2014 Sep 10.

PMID:
25891552
44.

Political Correctness of Medical Documentation.

Berger JR.

JAMA Neurol. 2015 Jun;72(6):624-5. doi: 10.1001/jamaneurol.2014.4535. No abstract available.

PMID:
25867915
45.

Infection risk in patients on multiple sclerosis therapeutics.

Williamson EM, Berger JR.

CNS Drugs. 2015 Mar;29(3):229-44. doi: 10.1007/s40263-015-0226-2. Review.

PMID:
25761739
46.

Persistence and pathogenesis of the neurotropic polyomavirus JC.

Wollebo HS, White MK, Gordon J, Berger JR, Khalili K.

Ann Neurol. 2015 Apr;77(4):560-70. doi: 10.1002/ana.24371. Epub 2015 Mar 6. Review.

47.

A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy.

Chahin S, Berger JR.

J Neurovirol. 2015 Dec;21(6):623-31. doi: 10.1007/s13365-014-0303-1. Epub 2014 Nov 18.

PMID:
25404234
48.

Presumptive human herpesvirus 6 myelopathy in an immunocompetent patient.

Kelley RE, Berger JR, Espey M, Kelley BP.

J Neurovirol. 2015 Feb;21(1):98-100. doi: 10.1007/s13365-014-0301-3. Epub 2014 Nov 4. No abstract available.

PMID:
25366662
49.

Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man.

Chalkley J, Berger JR.

J Neurovirol. 2014 Dec;20(6):640-3. doi: 10.1007/s13365-014-0288-9. Epub 2014 Nov 1. No abstract available.

PMID:
25366658
50.

Spinal epidural abscess.

Krishnamohan P, Berger JR.

Curr Infect Dis Rep. 2014 Nov;16(11):436. doi: 10.1007/s11908-014-0436-7.

PMID:
25230605

Supplemental Content

Loading ...
Support Center